CytomX Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: CytomX Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: CytomX Therapeutics Inc
Rating: 0.99058325
Author: Trendlyne DVM scores

about

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics...

2.76 0.00 (0.00%)

66.38% Fall from 52W High

2.3M

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.3 / 100

Technically Bearish

25.3 / 100

1Yr Price target upside is 344%

8 analysts

CytomX Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

CytomX Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics...

66.38% Fall from 52W High

SWOT Analysis

CytomX Therapeutics Inc Live Price Chart

CytomX Therapeutics Inc Live Price Chart